Gemtuzumab Oz treatment represents a unique advance in the therapy of aggressive myeloblastic leukemia, especially acute leukemic cancer (AML). This agent links a targeted molecule specific at the CD33 marker present https://sachinnhcz925788.pointblog.net/gemtuzumab-treatment-a-comprehensive-analysis-92392245